The purpose of this study is to collect evidence for or against the addition of olanzapine to standard nausea/vomiting prophylaxis in children receiving cyclophosphamide-based Bone Marrow Transplant conditioning. Its findings will be generalizable to children receiving other types of chemotherapy that have the potential to increase nausea/vomiting.
Thank you for your interest, but this study is recruiting by invitation only.
United States (Nationwide)
Kimberly Kasow
Pediatrics - Hematology/Oncology
Clinical or Medical
Interventional
Blood Conditions
Cancer (Pediatric Cancers, Leukemia, Lymphoma)
Child and Teen Health
Rare Diseases
19-1530
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
